Zero Point Five Therapeutics
Potomac
About Zero Point Five Therapeutics
Zero Point Five Therapeutics develops drugs to treat soil-transmitted helminthiasis. A pharmaceutical company is developing a single-dose formulation for soil-transmitted helminthiasis (STH). STH is a disease that primarily affects poor rural communities of color with inadequate sewage systems.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $11.6M
- Last round: Series Unknown (Jul 2025)
- Website: zeropointfivetherapeutics.com
Industries & Categories
Health Care, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/zero-point-five-therapeutics-141107 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.